People_

Professor Katy Bell

NHMRC Senior Research Fellow
Sydney School of Public Health
Faculty of Medicine and Health

Phone

0415 764 321

Fax

9351 7420

katy.bell@sydney.edu.au

Biographical details

I am a clinical epidemiologist and health services researcher with expertise in the evaluation of the clinical effectiveness of health care. My research aims to identify sustainable models of health care that benefit health, and do not cause harm. A new research theme focus on ways to decarbonise healthcare in order to decrease the substantial carbon emissions currently associated with the health sector.

Research interests

My research focouses on the evaluation of benefits and harms of medical tests used for screening, diagnosis and monitoring of people with chronic disease. Examples of chronic diseases where I have examined test use already, and /or are currently studying, include: cardiovascular disease, osteoporosis, osteoarthritis, melanoma, prostate, breast, thyroid and lung cancer.

Teaching and supervision

I contribute to curriculum development for the Clinical Epidemiology Program, School of Public Health, University of Sydney.

Current projects

I am leading a number of collaborative research projects relating to sustainability of health services. These include carbon footprint of healthcare, medical overuse (overtesting, overdiagnosis & overtreatment), melanoma surveillance,cardiovascular risk estimation for primary prevention of cardiovascular disease.

Associations

International Network for Epidemiology in Policy:https://epidemiologyinpolicy.org/

Australasian Epidemiological Association: https://aea.asn.au/

Medical Services Advisory Committee Evaluation Subcomittee (MSAC ESC):http://www.msac.gov.au/internet/msac/publishing.nsf/Content/esc-membership

Themes

Obesity, Diabetes and Cardiovascular Disease, Cancer, Healthy Ageing

Keywords

Cancer, Cardiovascular diseases, Osteoporosis

Approaches

Epidemiology, Statistics/Research Design

Current research students

Project title	Research student
Optimising trial processes and generating translational gains in self-monitoring trials Studies Within A Trial SWATs for the MELSELF Randomised Controlled trial of patient-led surveillance	Deonna ACKERMANN
Investigating new epidemiological methods for the analysis of a randomised controlled trial of patient led surveillance vs clinician led surveillance for detection of subsequent new melanoma the MEL SELF randomised controlled trial	Ellie MEDCALF
Incorporating environmental impacts into health technology assessments	Jake WILLIAMS
Melanoma in situ: Exploring Perceived Risk and Management Preferences	Zhuohan WU

Publications

By Type

Expand all

Book Chapters

Bell, K., Craig, J., Irwig, L. (2008). Monitoring the initial response to treatment. In P Glasziou, L Irwig and J K Aronson (Eds.), Evidence-based Medical Monitoring:From Principles to Practice, (pp. 75-89). Oxford: Blackwell Publishers. [More Information]

Journals

Shanmugalingam, R., Hall, N., Cheikh Hassan, H., Hennessy, A., Henry, A., Langsford, D., Lee, V., Munn, Z., Peek, M., Said, J., Medcalf, E., Bell, K., Ackermann, D., et al (2024). A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline. Medical Journal of Australia, 220(11), 582-591. [More Information]
Medcalf, E., Turner, R., Espinoza, D., He, V., Bell, K. (2024). Addressing missing outcome data in randomised controlled trials: A methodological scoping review. Contemporary Clinical Trials, 143, 107602. [More Information]
Kazda, L., Bell, K., Thomas, R., Hardiman, L., Barratt, A. (2024). Attention deficit/hyperactivity disorder (ADHD) in children: More focus on care and support, less on diagnosis. BMJ, , e073448. [More Information]
Bell, K., Nickel, B., Pathirana, T., Blennerhassett, M., Carter, S. (2024). Breast cancer screening from age 40 in the US. BMJ, , q1353. [More Information]
Farber, R., Houssami, N., McGeechan, K., Barratt, A., Bell, K. (2024). Breast cancer stage and size detected with film versus digital mammography in New South Wales, Australia: a population-based study using routinely collected data. Cancer Epidemiology Biomarkers and Prevention, 33(5). [More Information]
Adamson, A., Naik, G., Jones, M., Bell, K. (2024). Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method. BMJ Evidence-Based Medicine, , bmjebm-2023-112460. [More Information]
Sanders, S., Barratt, A., Buchbinder, R., Doust, J., Kazda, L., Jones, M., Glasziou, P., Bell, K. (2024). Evidence for overdiagnosis in noncancer conditions was assessed: a metaepidemiological study using the ‘Fair Umpire’ framework. Journal of Clinical Epidemiology, 165, 111215. [More Information]
Zhu, L., Hayen, A., Blanch, B., Engstrom, N., Doust, J., Semsarian, C., Bell, K. (2024). First implantable cardiac defibrillator insertions in New South Wales, 2005–2020: an analysis of linked administrative data. Medical Journal of Australia, 220(5), 249-257. [More Information]
Carter, S., Magrabi, F., Aquino, Y., Carolan, L., Frost, E., Degeling, C., Rogers, W., Scott, I., Bell, K., Fabrianesi, B. (2024). How should artificial intelligence be used in Australian health care? Recommendations from a citizens’ jury. Medical Journal of Australia, 220(8), 409-416. [More Information]
Williams, J., Bell, K., Morton, R., Dieng, M. (2024). Methods to Include Environmental Impacts in Health Economic Evaluations and Health Technology Assessments: A Scoping Review. Value in Health, 27(6), 794-804. [More Information]
Ackermann, D., Hersch, J., Janda, M., Bracken, K., Turner, R., Bell, K. (2024). Using the Behaviour Change Wheel to identify barriers and targeted strategies to improve adherence in randomised clinical trials: The example of MEL-SELF trial of patient-led surveillance for melanoma. Contemporary Clinical Trials, 140, 107513. [More Information]
Drabarek, D., Ackermann, D., Medcalf, E., Bell, K. (2023). Acceptability of a Hypothetical Reduction in Routinely Scheduled Clinic Visits Among Patients With History of a Localized Melanoma (MEL-SELF): Pilot Randomized Clinical Trial. JMIR Dermatology, 6. [More Information]
Bell, K., Stanaway, F., McCaffery, K., Shirley, M., Carter, S. (2023). Considering potential benefits, as well as harms, from the COVID-19 disruption to cancer screening and other healthcare services. Public Health Research and Practice, 33(1). [More Information]
Brennan, M., Bell, K., Hamid, G., Gilchrist, J., Gillingham, J. (2023). Consumer experiences of shame in clinical encounters for breast cancer treatment. “Who do you think you are– Angelina Jolie?”. Breast, 72, 103587. [More Information]
Shih, P., Ding, P., Carter, S., Stanaway, F., Horvath, A., Langguth, D., Saad, M., John, A., Bell, K. (2023). Direct-to-consumer tests advertised online in Australia and their implications for medical overuse: systematic online review and a typology of clinical utility. BMJ Open, 13(12). [More Information]
Petersen, M., Barratt, A., McGain, F., Skowno, J., Zhong, G., Weatherall, A., Bell, K., Pickles, K. (2023). Exploring anaesthetists’ views on the carbon footprint of anaesthesia and identifying opportunities and challenges for reducing its impact on the environment. Anaesthesia and Intensive Care. [More Information]
Williams, J., Bell, K., Morton, R., Dieng, M. (2023). Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance. Applied Health Economics and Health Policy, 21(1), 23-30. [More Information]
Semsarian, C., Ma, T., Nickel, B., Barratt, A., Varma, M., Delahunt, B., Millar, J., Parker, L., Glasziou, P., Bell, K. (2023). Low-risk prostate lesions: An evidence review to inform discussion on losing the “cancer” label. The Prostate, 83(6), 498-515. [More Information]
Zhu, L., Bell, K., Hayen, A. (2023). Methods to address selection bias in post-trial studies of legacy effects were evaluated. Journal of Clinical Epidemiology, 160, 110-116. [More Information]
Karki, S., Bell, K., Hayen, A., Liu, B., Cust, A., Olynyk, J., Irving, D. (2023). Regular high-frequency whole blood donation and risk of cardiovascular disease in middle-aged and older blood donors in Australia. Transfusion. [More Information]
Ma, T., Semsarian, C., Barratt, A., Parker, L., Pathmanathan, N., Nickel, B., Bell, K. (2023). Should low-risk DCIS lose the cancer label? An evidence review. Breast Cancer Research and Treatment. [More Information]
Ackermann, D., Bracken, K., Janda, M., Turner, R., Hersch, J., Drabarek, D., Bell, K. (2023). Strategies to Improve Adherence to Skin Self-examination and Other Self-management Practices in People at High Risk of Melanoma: A Scoping Review of Randomized Clinical Trials. JAMA Dermatology, 159(4), 432-440. [More Information]
Bell, K., Doust, J., Sanders, S., Buchbinder, R., Glasziou, P., Irwig, L., Jones, M., Moynihan, R., Kazda, L., Barratt, A. (2022). A novel methodological framework was described for detecting and quantifying overdiagnosis. Journal of Clinical Epidemiology, 148, 146-159. [More Information]
Medcalf, E., Huang, J., Arah, O., Harhay, M., Leeder, S., Bell, K. (2022). A survey of the use and impact of International Journal of Epidemiology's Education Corner. International Journal of Epidemiology, 51(5), 1687-1690. [More Information]
Schneuer, F., Bell, K., Dalton, C., Elshaug, A., Nassar, N. (2022). Adenotonsillectomy and adenoidectomy in children: The impact of timing of surgery and post-operative outcomes. Journal of Paediatrics and Child Health, 58(9), 1608-1615. [More Information]
Ackermann, D., Dieng, M., Medcalf, E., Jenkins, M., Van Kemenade, C., Janda, M., Turner, R., Cust, A., Morton, R., Irwig, L., Guitera, P., Hersch, J., Saw, R., Scolyer, R., Drabarek, D., Espinoza, D., Smit, A., Thompson, J., Bell, K., et al (2022). Assessing the Potential for Patient-led Surveillance after Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial. JAMA Dermatology, 158(1), 33-42. [More Information]
Kazda, L., McGeechan, K., Bell, K., Thomas, R., Barratt, A. (2022). Association of Attention-Deficit/Hyperactivity Disorder Diagnosis with Adolescent Quality of Life. JAMA Network Open, 5(10), E2236364. [More Information]
Medcalf, E., Taylor, A., Turner, R., Espinoza, D., Bell, K. (2022). Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow up? Statistical analysis plan for the MEL-SELF randomised controlled trial. Contemporary Clinical Trials, 117. [More Information]
McKinn, S., Javid, N., Newson, A., Freeman, L., Bonner, C., Shand, A., Nassar, N., Bell, K. (2022). Clinician views and experiences of non-invasive prenatal genetic screening tests in Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology, 62(6), 830-837. [More Information]
Mac, O., Ayre, J., Bell, K., McCaffery, K., Muscat, D. (2022). Comparison of Readability Scores for Written Health Information Across Formulas Using Automated vs Manual Measures. JAMA Network Open, 5(12), E2246051. [More Information]
Farber, R., Houssami, N., Barnes, I., McGeechan, K., Barratt, A., Bell, K. (2022). Considerations for Evaluating the Introduction of New Cancer Screening Technology: Use of Interval Cancers to Assess Potential Benefits and Harms. International Journal of Environmental Research and Public Health, 19(22). [More Information]
McKinn, S., Batcup, C., Cornell, S., Freeman, N., Doust, J., Bell, K., Figtree, G., Bonner, C. (2022). Decision Support Tools for Coronary Artery Calcium Scoring in the Primary Prevention of Cardiovascular Disease Do Not Meet Health Literacy Needs: A Systematic Environmental Scan and Evaluation. International Journal of Environmental Research and Public Health, 19(18). [More Information]
Semsarian, C., Ma, T., Nickel, B., Scolyer, R., Ferguson, P., Soyer, H., Parker, L., Barratt, A., Thompson, J., Bell, K. (2022). Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? British Journal of Dermatology, 186(6), 1030-1032. [More Information]
Bell, K., White, S., Hassan, O., Zhu, L., Scott, A., Clark, J., Glasziou, P. (2022). Evaluation of the Incremental Value of a Coronary Artery Calcium Score Beyond Traditional Cardiovascular Risk Assessment: A Systematic Review and Meta-analysis. JAMA Internal Medicine, 182(6), 634-642. [More Information]
Drabarek, D., Habgood, E., Janda, M., Hersch, J., Ackermann, D., Low, D., Low, C., Morton, R., Dieng, M., Cust, A., Morgan, A., Smith, E., Bell, K. (2022). Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study. JMIR Dermatology, 5(3). [More Information]
Petersen, M., Bell, K., Pickles, K., McGain, F., McAlister, S., Barratt, A. (2022). Health, financial and environmental impacts of unnecessary vitamin D testing: A triple bottom line assessment adapted for healthcare. BMJ Open, 12(8). [More Information]
Barratt, A., Bell, K., Charlesworth, K., McGain, F. (2022). High value health care is low carbon health care. Medical Journal of Australia, 216(2), 67-68. [More Information]
Harhay, M., Bell, K., Huang, J., Arah, O. (2022). IJE's Education Corner turns 10! Looking back and looking forward. International Journal of Epidemiology, 51(5), 1357-1360. [More Information]
Pathirana, T., Pickles, K., Riikonen, J., Tikkinen, K., Bell, K., Glasziou, P. (2022). Including Information on Overdiagnosis in Shared Decision Making: A Review of Prostate Cancer Screening Decision Aids. MDM Policy and Practice, 7(2). [More Information]
Kazda, L., McGeechan, K., Bell, K., Thomas, R., Barratt, A. (2022). Increased diagnosis of attention-deficit hyperactivity disorder despite stable hyperactive/inattentive behaviours: evidence from two birth cohorts of Australian children. The Journal of Child Psychology and Psychiatry. [More Information]
Besser, R., Bell, K., Couper, J., Ziegler, A., Wherrett, D., Knip, M., Speake, C., Casteels, K., Driscoll, K., Jacobsen, L., Craig, M., et al (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents. Pediatric Diabetes, 23(8), 1175-1187. [More Information]
Bell, K., Zhu, L., Glasziou, P. (2022). Keeping Score-Appropriate and Timely Use of CACS-Reply. JAMA Internal Medicine, 182(11), 1233-1234. [More Information]
Gregory, G., Zhu, L., Hayen, A., Bell, K. (2022). Learning from the pandemic: Mortality trends and seasonality of deaths in Australia in 2020. International Journal of Epidemiology, 51(3), 718-726. [More Information]
Bell, K., Nijsten, T. (2022). Melanoma overdiagnosis: why it matters and what can be done about it. British Journal of Dermatology, 187(4), 459-460. [More Information]
Drabarek, D., Habgood, E., Ackermann, D., Hersch, J., Janda, M., Morton, R., Guitera, P., Peter Soyer, H., Collgros Totosaus, H., Cust, A., Saw, R., Dieng, M., Bell, K., et al (2022). Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study. JMIR Dermatology, 5(4). [More Information]
Meiser, B., Woodward, P., Gleeson, M., Kentwell, M., Mar Fan, H., Antill, Y., Butow, P., Boyle, F., Best, M., Taylor, N., Bell, K., et al (2022). Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients. Familial Cancer, 21(2), 157-166. [More Information]
Arroyo, N., Bell, K., Hsiao, V., Fernandes-Taylor, S., Alagoz, O., Zhang, Y., Davies, L., Francis, D. (2022). Prevalence of Subclinical Papillary Thyroid Cancer by Age: Meta-analysis of Autopsy Studies. Journal of Clinical Endocrinology and Metabolism, 107(10), 2945-2952. [More Information]
White, S., Gong, H., Zhu, L., Doust, J., Loh, T., Lord, S., Horvath, A., McGeechan, K., Bell, K. (2022). Simulations found within-subject measurement variation in glycaemic measures may cause overdiagnosis of prediabetes and diabetes. Journal of Clinical Epidemiology, 145, 20-28. [More Information]
Muscat, D., Cvejic, E., Bell, K., Smith, J., Morris, G., Jansen, J., Thomas, R., Bonner, C., Doust, J., McCaffery, K. (2022). The impact of health literacy on psychosocial and behavioural outcomes among people at low risk of cardiovascular disease. Preventive Medicine, 156, 106980. [More Information]
Pathirana, T., Sequeira, R., Del Mar, C., Dickinson, J., Armstrong, B., Bell, K., Glasziou, P. (2022). Trends in Prostate Specific Antigen (PSA) testing and prostate cancer incidence and mortality in Australia: A critical analysis. Cancer Epidemiology, 77, 102093-1-102093-6. [More Information]
Keers, G., Yamada, K., Pickles, K., Bell, K., Black, K., Bateson, D., Dodd, R. (2022). Understanding women’s choices for management of cervical intraepithelial neoplasia 2 (CIN2): Qualitative analysis of a randomised experimental study. Australian and New Zealand Journal of Obstetrics and Gynaecology, 62(1), 125-132. [More Information]
Luigjes-Huizer, Y., Tauber, N., Humphris, G., Kasparian, N., Lam, W., Lebel, S., Simard, S., Smith, A., Zachariae, R., Afiyanti, Y., Bell, K., et al (2022). What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psycho-Oncology, 31(6), 879-892. [More Information]
Zhu, L., Bell, K., Nayak, A., Hayen, A. (2021). A methods review of posttrial follow-up studies of cardiovascular prevention finds potential biases in estimating legacy effects. Journal of Clinical Epidemiology, 131, 51-58. [More Information]
Dodd, R., Cvejic, E., Bell, K., Black, K., Bateson, D., Smith, M., Mac, O., McCaffery, K. (2021). Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study. Gynecologic Oncology, 161(1), 179-187. [More Information]
Muscat, D., Morris, G., Bell, K., Cvejic, E., Smith, J., Jansen, J., Thomas, R., Bonner, C., Doust, J., McCaffery, K. (2021). Benefits and Harms of Hypertension and High-Normal Labels: A Randomized Experiment. Circulation: Cardiovascular Quality and Outcomes, 14(4):e007160(4), e007160. [More Information]
Ackermann, D., Smit, A., Janda, M., Van Kemenade, C., Dieng, M., Morton, R., Turner, R., Cust, A., Irwig, L., Hersch, J., Guitera, P., Saw, R., Drabarek, D., Espinoza, D., Thompson, J., Scolyer, R., Bell, K., et al (2021). Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial. Trials, 22(1), 324. [More Information]
Byambasuren, O., Dobler, C., Bell, K., Rojas, D., Clark, J., McLaws, M., Glasziou, P. (2021). Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review. PloS One, 16, e0248946. [More Information]
Stanaway, F., Irwig, L., Teixeira-Pinto, A., Bell, K. (2021). COVID-19: estimated number of deaths if Australia had experienced a similar outbreak to England and Wales. Medical Journal of Australia, 214(2), 95-9.50E+02. [More Information]
Leeflang, M., Bell, K., Deeks, J., Dinnes, J., Doust, J., Korevaar, D., Lord, S., Spijker, R. (2021). Electronic and animal noses for detecting SARS-CoV-2 infection. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2021 (6). [More Information]
Bell, K., Glasziou, P., Stanaway, F., Bossuyt, P., Irwig, L. (2021). Equity and evidence during vaccine rollout: stepped wedge cluster randomised trials could help. BMJ, 372, n435. [More Information]
Gibson, M., Scolyer, R., Soyer, H., Ferguson, P., McGeechan, K., Irwig, L., Bell, K. (2021). Estimating the potential impact of interventions to reduce over-calling and under-calling of melanoma. Journal of the European Academy of Dermatology and Venereology, 35(7), 1519-1527. [More Information]
Leclair, K., Bell, K., Furuya-Kanamori, L., Doi, S., Francis, D., Davies, L. (2021). Evaluation of Gender Inequity in Thyroid Cancer Diagnosis: Differences by Sex in US Thyroid Cancer Incidence Compared with a Meta-analysis of Subclinical Thyroid Cancer Rates at Autopsy. JAMA Internal Medicine, 181(10), 1351-1358. [More Information]
Doust, J., Bell, K., Leeflang, M., Dinnes, J., Lord, S., Mallett, S., Van De Wijgert, J., Sandberg, S., Adeli, K., Deeks, J., Horvath, A., et al (2021). Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection. BMJ, 372, n568. [More Information]
Bell, K., Stanaway, F., Irwig, L., Horvath, A., Teixeira-Pinto, A., Loy, C. (2021). How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions. Medical Journal of Australia, 214(2), 69-7.30E+02. [More Information]
Katz, I., Irwig, L., McGeehan, K., Bell, K. (2021). I need an exact margin measurement for this basal cell carcinoma!. Journal of Clinical Pathology. [More Information]
Farber, R., Houssami, N., Wortley, S., Jacklyn, G., Marinovich, M., McGeechan, K., Barratt, A., Bell, K. (2021). Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis. Journal of the National Cancer Institute, 113(1), 16-26. [More Information]
Bell, K., Loy, C., Cust, A., Teixeira-Pinto, A. (2021). Mendelian Randomization in Cardiovascular Research: Establishing Causality When There Are Unmeasured Confounders. Circulation: Cardiovascular Quality and Outcomes, 14(1), e005623. [More Information]
Kazda, L., Bell, K., Thomas, R., McGeechan, K., Sims, R., Barratt, A. (2021). Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review. JAMA Network Open, 4(4), e215335. [More Information]
Bell, K., Doust, J., McGeechan, K., Barratt, A., Hayen, A., Semsarian, C., Irwig, L. (2021). Reply. Journal of Hypertension, 39(5), 1045-1046. [More Information]
Ma, T., Semsarian, C., Barratt, A., Parker, L., Kumarasinghe, M., Bell, K., Nickel, B. (2021). Rethinking Low-Risk Papillary Thyroid Cancers < 1cm (Papillary Microcarcinomas): An Evidence Review for Recalibrating Diagnostic Thresholds and/or Alternative Labels. Thyroid, 31(11), 1626-1638. [More Information]
Loh, T., Smith, A., Bell, K., Lord, S., Ceriotti, F., Jones, G., Bossuyt, P., Sandberg, S., Horvath, A. (2021). Setting analytical performance specifications using HbA1c as a model measurand. Clinica Chimica Acta, 523, 407-414. [More Information]
Loh, T., Lord, S., Bell, K., Bohn, M., Lim, C., Markus, C., Fares Taie, H., Adeli, K., Lippi, G., Sandberg, S., et al (2021). Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing. Clinical Biochemistry, 88, 18-22. [More Information]
Bell, K., McGeechan, K., Horvath, A., Barratt, A., Hayen, A., Semsarian, C., Irwig, L. (2021). The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines. Journal of Hypertension, 39(2), 236-242. [More Information]
Karki, S., Davison, T., Liu, B., Bell, K., Olynyk, J., Hayen, A., Irving, D. (2021). Visits to general practitioners after iron-related deferrals from blood donation in middle-aged and older Australian blood donors. Transfusion, 61(12), 3335-3343. [More Information]
Doust, J., Treadwell, J., Bell, K. (2021). Widening Disease Definitions: What Can Physicians Do? American Family Physician, 103(3), 138-140.
Karki, S., Gemelli, C., Davison, T., Masser, B., Marks, D., Bell, K., Liu, B., Hayen, A., van den Hurk, K., Irving, D. (2021). Willingness of blood donors in Australia to provide additional data and blood sample for health research. Transfusion, 61(10), 2855-2861. [More Information]
Bell, K. (2020). Causal inference in melanoma epidemiology using Mendelian randomization. British Journal of Dermatology, 182(1), 7-23. [More Information]
Byambasuren, O., Cardona, M., Bell, K., Clark, J., McLaws, M., Glasziou, P. (2020). Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. Association of Medical Microbiology and Infectious Disease Canada. Journal, 5(4), 223-234. [More Information]
Glasziou, P., Jones, M., Pathirana, T., Barratt, A., Bell, K. (2020). Estimating the magnitude of cancer overdiagnosis in Australia. Medical Journal of Australia, 212(4), 163-168. [More Information]
Glasziou, P., Bell, K., Barratt, A. (2020). Estimating the magnitude of cancer overdiagnosis in Australia. Medical Journal of Australia, 213(4), 189-189.e1. [More Information]
Doust, J., Bonner, C., Bell, K. (2020). Future directions in cardiovascular disease risk prediction. Australian Journal of General Practice, 49(8), 488-494. [More Information]
Bach, A., Lo, K., Pathirana, T., Glasziou, P., Barratt, A., Jones, M., Bell, K. (2020). Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk. Medical Journal of Australia, 212(1), 17-22. [More Information]
Zhu, L., Hayen, A., Bell, K. (2020). Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study. Cardiovascular Diabetology, 19(1), 28. [More Information]
Bell, K., Irwig, L., Nickel, B., Hersch, J., Hayen, A., Barratt, A. (2020). Mammography screening for breast cancer—the UK Age trial. The Lancet Oncology, 21(11), e504. [More Information]
Doust, J., Bell, K., Glasziou, P. (2020). Potential Consequences of Changing Disease Classifications. JAMA, 323(10), 921-922. [More Information]
McAlister, S., Barratt, A., Bell, K., McGain, F. (2020). The carbon footprint of pathology testing. Medical Journal of Australia, 212(8), 377-382. [More Information]
Oremus, M., Taylor-Wilson, R., Aldrich, M., Bell, K., Gaudino, J., Payne, J., Raynes-Greenow, C., Sim, F., Smith, M., Weiss, S., Zhang, Y. (2020). The role of epidemiologists in SARS-CoV-2 and COVID-19 research. Public Health, 190, e3-e4. [More Information]
Smith, L., Barratt, A., Buchbinder, R., Harris, I., Doust, J., Bell, K. (2020). Trends in knee magnetic resonance imaging, arthroscopies and joint replacements in older Australians: still too much low-value care? ANZ Journal of Surgery, 90(5), 833-839. [More Information]
Lam, J., Pickles, K., Stanaway, F., Bell, K. (2020). Why clinicians overtest: development of a thematic framework. BMC Health Services Research, 20(1), 1011. [More Information]
Bell, K., Semsarian, C., Doust, J. (2020). Why We Might Not Need to Stress About Ruling Out Inducible Myocardial Ischemia. Annals of Internal Medicine, 172(3), 214-215. [More Information]
Zhu, L., Bell, K., Hayen, A. (2019). Estimated legacy effects from simulated post-trial data were less biased than from combined trial/post-trial data. Journal of Clinical Epidemiology, 114, 30-37. [More Information]
Kazda, L., Bell, K., Thomas, R., McGeechan, K., Barratt, A. (2019). Evidence of potential overdiagnosis and overtreatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents: protocol for a scoping review. BMJ Open, 9(11), 1-5. [More Information]
Bonner, C., McKinn, S., McCaffery, K., Glasziou, P., Irwig, L., Doust, J., Jansen, J., Bell, K. (2019). Is the NHS 'Heart Age Test' too much medicine? British Journal of General Practice, 69(688), 560-561. [More Information]
Pathirana, T., Hayen, A., Doust, J., Glasziou, P., Bell, K. (2019). Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach. BMJ Open, 9(3), 1-7. [More Information]
Dieng, M., Smit, A., Hersch, J., Morton, R., Cust, A., Irwig, L., Low, D., Low, C., Bell, K. (2019). Patients' Views About Skin Self-examination After Treatment for Localized Melanoma. JAMA Dermatology, 155(8), 914-921. [More Information]
Thomas, E., Guppy, M., Straus, S., Bell, K., Glasziou, P. (2019). Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies. BMJ Open, 9(6), 1-13. [More Information]
Bell, K., Doust, J., Glasziou, P., Cullen, L., Harris, I., Smith, L., Buchbinder, R., Barratt, A. (2019). Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example? Annals of Internal Medicine, 170(4), 259-261. [More Information]
Thurber, K., Bell, K. (2019). Socio-economic disadvantage and cardiovascular risk factors in young Aboriginal and Torres Strait Islander Australians. Medical Journal of Australia, 211, 259-260. [More Information]
Bell, K., Macaskill, P., Loy, C. (2019). Test accuracy and potential sources of bias in diagnostic test evaluation. Medical Journal of Australia, 212(1), 10-1.30E+02. [More Information]
Morony, S., Weir, K., Bell, K., Biggs, J., Duncan, G., Nutbeam, D., McCaffery, K. (2018). A stepped wedge cluster randomised trial of nurse-delivered Teach-Back in a consumer telehealth service. PloS One, 13(10), 1-20. [More Information]
Bell, K., Cust, A. (2018). Beyond country-specific incidence and mortality: the global burden of melanoma. British Journal of Dermatology, 178(2), 315-316. [More Information]
Barratt, A., Bell, K., Jacklyn, G. (2018). Demonstration of Classic Screening Biases, Not Additional Benefit of Annual Over Biennial Screening. Journal of the American College of Radiology, 15(10), 1360. [More Information]
Bell, K., Doust, J., Glaszious, P. (2018). Incremental Benefits and Harms of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. JAMA Internal Medicine, 178(6), 755-757. [More Information]
Nayak, A., Hayen, A., Zhu, L., McGeechan, K., Glasziou, P., Irwig, L., Doust, J., Gregory, G., Bell, K. (2018). Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis. BMJ Open, 8(9), 1-11. [More Information]
Jacklyn, G., McGeechan, K., Houssami, N., Bell, K., Glasziou, P., Barratt, A. (2018). Overdiagnosis due to screening mammography for women aged 40 years and over [Intervention Protocol]. Cochrane Database of Systematic Reviews, 2018 (7), 1-17. [More Information]
Lim, W., Morton, R., Turner, R., Jenkins, M., Guitera, P., Irwig, L., Webster, A., Dieng, M., Saw, R., Low, D., Bell, K., et al (2018). Patient preferences for follow-up after recent excision of a localized melanoma. JAMA Dermatology, 154(4), 420-427. [More Information]
Hajati, F., Atlantis, E., Bell, K., Girosi, F. (2018). Patterns and trends of potentially inappropriate high-density lipoprotein cholesterol testing in Australian adults at high risk of cardiovascular disease from 2008 to 2014: analysis of linked individual patient data from the Australian Medicare Benefits Schedule and Pharmaceutical Benefits Scheme. BMJ Open, 8(3), 1-10. [More Information]
Bell, K., Azizi, L., Nilsson, P., Hayen, A., Irwig, L., Ostgren, C., Sundrom, J. (2018). Prognostic impact of systolic blood pressure variability in people with diabetes. PloS One, 13(4), 1-11. [More Information]
Bonner, C., Bell, K., Jansen, J., Glasziou, P., Irwig, L., Doust, J., McCaffery, K. (2018). Should heart age calculators be used alongside absolute cardiovascular disease risk assessment? BMC Cardiovascular Disorders, 18(1), 1-8. [More Information]
Bell, K., Cust, A., Scolyer, R. (2018). The importance of population-based estimates of melanocytic pathology. JAMA Dermatology, 154(1), 15-17. [More Information]
Lim, W., Turner, R., Morton, R., Jenkins, M., Irwig, L., Webster, A., Dieng, M., Saw, R., Guitera, P., Low, D., Bell, K., et al (2018). Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma. BMC Health Services Research, 18(1), 1-9. [More Information]
Jacklyn, G., Bell, K., Hayen, A. (2017). Assessing the efficacy of cancer screening. Public Health Research and Practice, 27(3), 1-6. [More Information]
Bell, K., Hayen, A., Glasziou, P., Irwig, L., Bauer, D. (2017). Change in bone mineral density is an indicator of treatment-related antifracture effect. Annals of Internal Medicine, 166(2), 152-152. [More Information]
Bell, K., Hayen, A., Glasziou, P., Mitchell, A., Farris, M., Wright, J., Duerr, H., Mitchell, P., Irwig, L. (2017). Early CRT monitoring using time-domain optical coherence tomography does not add to visual acuity for predicting visual loss in patients with central retinal vein occlusion treated with intravitreal ranibizumab a secondary analysis of trial data. Retina, 37(3), 509-514. [More Information]
Bell, K., Mehta, Y., Turner, R., Morton, R., Dieng, M., Saw, R., Guitera, P., McCaffery, K., Low, D., Low, C., Jenkins, M., Irwig, L., Webster, A. (2017). Fear of new or recurrent melanoma after treatment for localised melanoma. Psycho-Oncology, 26(11), 1784-1791. [More Information]
Jansen, J., McKinn, S., Bonner, C., Irwig, L., Doust, J., Glasziou, P., Bell, K., Naganathan, V., McCaffery, K. (2017). General practitioners' decision making about primary prevention of cardiovascular disease in older adults: A qualitative study. PloS One, 12(1), 1-13. [More Information]
Thomas, E., Del Mar, C., Glasziou, P., Wright, G., Barratt, A., Bell, K. (2017). Prevalence of incidental breast cancer and precursor lesions in autopsy studies: A systematic review and meta-analysis. BMC Cancer, 17(1), 1-10. [More Information]
Sanders, S., Rathbone, J., Bell, K., Glasziou, P., Doust, J. (2017). Systematic review of the effects of care provided with and without diagnostic clinical prediction rules. Diagnostic and Prognostic Research, 1(1), 1-17. [More Information]
Jacklyn, G., McGeechan, K., Irwig, L., Houssami, N., Morrell, S., Bell, K., Barratt, A. (2017). Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography. Breast Cancer Research and Treatment, 166(3), 843-854. [More Information]
Bell, K., McCullough, A., Del Mar, C., Glasziou, P. (2017). What's the uptake? Pragmatic RCTs may be used to estimate uptake, and thereby population impact of interventions, but better reporting of trial recruitment processes is needed. BMC Medical Research Methodology, 17(1), 1-7. [More Information]
Bell, K., Hayen, A., Glasziou, P., Irwig, L., Eastell, R., Harrison, S., Black, D., Bauer, D. (2016). Potential Usefulness of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy Among Women With Osteoporosis: Secondary Analysis of Randomized Controlled Trial Data. Journal of Bone and Mineral Research, 31(9), 1767-1773. [More Information]
Furuya-Kanamori, L., Bell, K., Clark, J., Glasziou, P., Doi, S. (2016). Prevalence of differentiated thyroid cancer in autopsy studies over six decades: A meta-analysis. Journal of Clinical Oncology, 34(30), 3672-3679. [More Information]
Bell, K., Bossuyt, P., Glasziou, P., Irwig, L. (2015). Assessment of changes to screening programmes: why randomisation is important. BMJ, 350, 1-4. [More Information]
Memari, N., Hayen, A., Bell, K., Rychetnik, L., Morton, R., McCaffery, K., Thompson, J., Irwig, L., Turner, R. (2015). How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center? Annals of Surgical Oncology, 22(Supp 3), 1164-1171. [More Information]
Bell, K., Del Mar, C., Wright, G., Dickinson, J., Glasziou, P. (2015). Prevalence of incidental prostate cancer: A systematic review of autopsy studies. International Journal of Cancer, 137(7), 1749-1757. [More Information]
Bell, K., McCaffery, K., Irwig, L. (2015). Screening tests for gonorrhoea should first do no harm. Medical Journal of Australia, 202(6), 281-282. [More Information]
Bell, K., Beller, E., Sundstrom, J., McGeechan, K., Hayen, A., Irwig, L., Neal, B., Glasziou, P. (2014). Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data. BMJ Open, 4(9), 1-9. [More Information]
Bell, K., Glasziou, P., Hayen, A., Irwig, L. (2014). Criteria for monitoring tests were described: validity, responsiveness, detectability of long-term change, and practicality. Journal of Clinical Epidemiology, 67(2), 152-159. [More Information]
Bell, K., Hayen, A., Irwig, L., Takahashi, O., Ohde, S., Glasziou, P. (2013). When to remeasure cardiovascular risk in untreated people at low and intermediate risk: observational study. BMJ, 346(7906), 1-8. [More Information]
Hayden, A., Bell, K., Glasziou, P., Irwig, L. (2012). A counterargument to encounter frequency and target achievement: measurement variability. Archives of Internal Medicine, 172(4), 374-375. [More Information]
Bell, K., Hayen, A., McGeechan, K., Neal, B., Irwig, L. (2012). Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk. European Journal of Preventive Cardiology, 19(6), 1474-1485. [More Information]
Bell, K., Hayen, A., Irwig, L., Hochberg, M., Ensrud, K., Cummings, S., Bauer, D. (2012). The Potential Value of Monitoring Bone Turnover Markers Among Women on Alendronate. Journal of Bone and Mineral Research, 27(1), 195-201. [More Information]
Bell, K., Kirby, A., Hayen, A., Irwig, L., Glasziou, P. (2011). Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data. BMJ: British Medical Journal, 342(7791), 1-7. [More Information]
Turner, R., Bell, K., Morton, R., Hayen, A., Francken, A., Howard, K., Armstrong, B., Thompson, J., Irwig, L. (2011). Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma. Journal of Clinical Oncology, 29(35), 4641-4646. [More Information]
Hayen, A., Bell, K., Glasziou, P., Neal, B., Irwig, L. (2010). Monitoring Adherence to Medication by Measuring Change in Blood Pressure. Hypertension, 56(4), 612-616. [More Information]
Bell, K., Hayen, A., Macaskill, P., Craig, J., Neal, B., Fox, K., Remme, W., Asselbergs, F., van Gilst, W., MacMahon, S., Irwig, L., et al (2010). Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor-Based Regimens. An Individual Patient Data Meta-Analysis From Randomized, Placebo-Controlled Trials. Hypertension, 56(3), 533-539. [More Information]
Bell, K., Irwig, L., Hayen, A., Macaskill, P., Craig, J. (2010). Should response rules be used to decide continued subsidy of very expensive drugs? A checklist for decision makers. Pharmacoepidemiology and Drug Safety, 19(1), 99-105. [More Information]
Bell, K., Hayen, A., Irwig, L., Macaskill, P., Craig, J., Ensrud, K., Bauer, D. (2010). The Value of Routine BMD Monitoring After Starting Bisphosphonate Treatment. Journal of Bone and Mineral Research, 25(1), 173-174. [More Information]
Gupta, S., Wratten, C., Kilmurray, J., Nash, S., Seldon, M., O'Brien, P., Bell, K., Denham, J. (2009). Is there a relationship between skin erythema and fatigue in women undergoing irradiation after breast conserving surgery for early breast cancer? A prospective study. Asia-Pacific Journal of Clinical Oncology, 5(4), 257-263. [More Information]
Bell, K., Hayen, A., Macaskill, P., Craig, J., Neal, B., Irwig, L. (2009). Mixed models showed no need for initial response monitoring after starting antihypertensive therapy. Journal of Clinical Epidemiology, 62, 650-659. [More Information]
Lincz, L., Gupta, S., Wratten, C., Kilmurray, J., Nash, S., Seldon, M., O'Brien, P., Bell, K., Denham, J. (2009). Thrombin generation as a predictor of radiotherapy induced skin erythema. Radiotherapy and Oncology, 90(1), 136-140. [More Information]
Bell, K., Hayen, A., Macaskill, P., Irwig, L., Craig, J., Ensrud, K., Bauer, D. (2009). Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ: British Medical Journal, 338(7710), 1-5. [More Information]
Bell, K., Irwig, L., Craig, J., Macaskill, P. (2008). Use of randomised trials to decide when to monitor response to new treatment. BMJ: British Medical Journal, 336, 361-365. [More Information]
Bell, K., Wattie, M., Byth Wilson, K., Silvestrini, R., Clark, P., Stachowski, E., Benson, E. (2003). Procalcitonin: A marker of bacteraemia is SIRS. Anaesthesia and Intensive Care, 31(6), 629-636.

show 141 more

By Year

Expand all

2024

Shanmugalingam, R., Hall, N., Cheikh Hassan, H., Hennessy, A., Henry, A., Langsford, D., Lee, V., Munn, Z., Peek, M., Said, J., Medcalf, E., Bell, K., Ackermann, D., et al (2024). A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) hypertension in pregnancy guideline. Medical Journal of Australia, 220(11), 582-591. [More Information]
Medcalf, E., Turner, R., Espinoza, D., He, V., Bell, K. (2024). Addressing missing outcome data in randomised controlled trials: A methodological scoping review. Contemporary Clinical Trials, 143, 107602. [More Information]
Kazda, L., Bell, K., Thomas, R., Hardiman, L., Barratt, A. (2024). Attention deficit/hyperactivity disorder (ADHD) in children: More focus on care and support, less on diagnosis. BMJ, , e073448. [More Information]
Bell, K., Nickel, B., Pathirana, T., Blennerhassett, M., Carter, S. (2024). Breast cancer screening from age 40 in the US. BMJ, , q1353. [More Information]
Farber, R., Houssami, N., McGeechan, K., Barratt, A., Bell, K. (2024). Breast cancer stage and size detected with film versus digital mammography in New South Wales, Australia: a population-based study using routinely collected data. Cancer Epidemiology Biomarkers and Prevention, 33(5). [More Information]
Adamson, A., Naik, G., Jones, M., Bell, K. (2024). Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method. BMJ Evidence-Based Medicine, , bmjebm-2023-112460. [More Information]
Sanders, S., Barratt, A., Buchbinder, R., Doust, J., Kazda, L., Jones, M., Glasziou, P., Bell, K. (2024). Evidence for overdiagnosis in noncancer conditions was assessed: a metaepidemiological study using the ‘Fair Umpire’ framework. Journal of Clinical Epidemiology, 165, 111215. [More Information]
Zhu, L., Hayen, A., Blanch, B., Engstrom, N., Doust, J., Semsarian, C., Bell, K. (2024). First implantable cardiac defibrillator insertions in New South Wales, 2005–2020: an analysis of linked administrative data. Medical Journal of Australia, 220(5), 249-257. [More Information]
Carter, S., Magrabi, F., Aquino, Y., Carolan, L., Frost, E., Degeling, C., Rogers, W., Scott, I., Bell, K., Fabrianesi, B. (2024). How should artificial intelligence be used in Australian health care? Recommendations from a citizens’ jury. Medical Journal of Australia, 220(8), 409-416. [More Information]
Williams, J., Bell, K., Morton, R., Dieng, M. (2024). Methods to Include Environmental Impacts in Health Economic Evaluations and Health Technology Assessments: A Scoping Review. Value in Health, 27(6), 794-804. [More Information]
Ackermann, D., Hersch, J., Janda, M., Bracken, K., Turner, R., Bell, K. (2024). Using the Behaviour Change Wheel to identify barriers and targeted strategies to improve adherence in randomised clinical trials: The example of MEL-SELF trial of patient-led surveillance for melanoma. Contemporary Clinical Trials, 140, 107513. [More Information]

show 8 more

2023

Drabarek, D., Ackermann, D., Medcalf, E., Bell, K. (2023). Acceptability of a Hypothetical Reduction in Routinely Scheduled Clinic Visits Among Patients With History of a Localized Melanoma (MEL-SELF): Pilot Randomized Clinical Trial. JMIR Dermatology, 6. [More Information]
Bell, K., Stanaway, F., McCaffery, K., Shirley, M., Carter, S. (2023). Considering potential benefits, as well as harms, from the COVID-19 disruption to cancer screening and other healthcare services. Public Health Research and Practice, 33(1). [More Information]
Brennan, M., Bell, K., Hamid, G., Gilchrist, J., Gillingham, J. (2023). Consumer experiences of shame in clinical encounters for breast cancer treatment. “Who do you think you are– Angelina Jolie?”. Breast, 72, 103587. [More Information]
Shih, P., Ding, P., Carter, S., Stanaway, F., Horvath, A., Langguth, D., Saad, M., John, A., Bell, K. (2023). Direct-to-consumer tests advertised online in Australia and their implications for medical overuse: systematic online review and a typology of clinical utility. BMJ Open, 13(12). [More Information]
Petersen, M., Barratt, A., McGain, F., Skowno, J., Zhong, G., Weatherall, A., Bell, K., Pickles, K. (2023). Exploring anaesthetists’ views on the carbon footprint of anaesthesia and identifying opportunities and challenges for reducing its impact on the environment. Anaesthesia and Intensive Care. [More Information]
Williams, J., Bell, K., Morton, R., Dieng, M. (2023). Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance. Applied Health Economics and Health Policy, 21(1), 23-30. [More Information]
Semsarian, C., Ma, T., Nickel, B., Barratt, A., Varma, M., Delahunt, B., Millar, J., Parker, L., Glasziou, P., Bell, K. (2023). Low-risk prostate lesions: An evidence review to inform discussion on losing the “cancer” label. The Prostate, 83(6), 498-515. [More Information]
Zhu, L., Bell, K., Hayen, A. (2023). Methods to address selection bias in post-trial studies of legacy effects were evaluated. Journal of Clinical Epidemiology, 160, 110-116. [More Information]
Karki, S., Bell, K., Hayen, A., Liu, B., Cust, A., Olynyk, J., Irving, D. (2023). Regular high-frequency whole blood donation and risk of cardiovascular disease in middle-aged and older blood donors in Australia. Transfusion. [More Information]
Ma, T., Semsarian, C., Barratt, A., Parker, L., Pathmanathan, N., Nickel, B., Bell, K. (2023). Should low-risk DCIS lose the cancer label? An evidence review. Breast Cancer Research and Treatment. [More Information]
Ackermann, D., Bracken, K., Janda, M., Turner, R., Hersch, J., Drabarek, D., Bell, K. (2023). Strategies to Improve Adherence to Skin Self-examination and Other Self-management Practices in People at High Risk of Melanoma: A Scoping Review of Randomized Clinical Trials. JAMA Dermatology, 159(4), 432-440. [More Information]

show 8 more

2022

Bell, K., Doust, J., Sanders, S., Buchbinder, R., Glasziou, P., Irwig, L., Jones, M., Moynihan, R., Kazda, L., Barratt, A. (2022). A novel methodological framework was described for detecting and quantifying overdiagnosis. Journal of Clinical Epidemiology, 148, 146-159. [More Information]
Medcalf, E., Huang, J., Arah, O., Harhay, M., Leeder, S., Bell, K. (2022). A survey of the use and impact of International Journal of Epidemiology's Education Corner. International Journal of Epidemiology, 51(5), 1687-1690. [More Information]
Schneuer, F., Bell, K., Dalton, C., Elshaug, A., Nassar, N. (2022). Adenotonsillectomy and adenoidectomy in children: The impact of timing of surgery and post-operative outcomes. Journal of Paediatrics and Child Health, 58(9), 1608-1615. [More Information]
Ackermann, D., Dieng, M., Medcalf, E., Jenkins, M., Van Kemenade, C., Janda, M., Turner, R., Cust, A., Morton, R., Irwig, L., Guitera, P., Hersch, J., Saw, R., Scolyer, R., Drabarek, D., Espinoza, D., Smit, A., Thompson, J., Bell, K., et al (2022). Assessing the Potential for Patient-led Surveillance after Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial. JAMA Dermatology, 158(1), 33-42. [More Information]
Kazda, L., McGeechan, K., Bell, K., Thomas, R., Barratt, A. (2022). Association of Attention-Deficit/Hyperactivity Disorder Diagnosis with Adolescent Quality of Life. JAMA Network Open, 5(10), E2236364. [More Information]
Medcalf, E., Taylor, A., Turner, R., Espinoza, D., Bell, K. (2022). Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow up? Statistical analysis plan for the MEL-SELF randomised controlled trial. Contemporary Clinical Trials, 117. [More Information]
McKinn, S., Javid, N., Newson, A., Freeman, L., Bonner, C., Shand, A., Nassar, N., Bell, K. (2022). Clinician views and experiences of non-invasive prenatal genetic screening tests in Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology, 62(6), 830-837. [More Information]
Mac, O., Ayre, J., Bell, K., McCaffery, K., Muscat, D. (2022). Comparison of Readability Scores for Written Health Information Across Formulas Using Automated vs Manual Measures. JAMA Network Open, 5(12), E2246051. [More Information]
Farber, R., Houssami, N., Barnes, I., McGeechan, K., Barratt, A., Bell, K. (2022). Considerations for Evaluating the Introduction of New Cancer Screening Technology: Use of Interval Cancers to Assess Potential Benefits and Harms. International Journal of Environmental Research and Public Health, 19(22). [More Information]
McKinn, S., Batcup, C., Cornell, S., Freeman, N., Doust, J., Bell, K., Figtree, G., Bonner, C. (2022). Decision Support Tools for Coronary Artery Calcium Scoring in the Primary Prevention of Cardiovascular Disease Do Not Meet Health Literacy Needs: A Systematic Environmental Scan and Evaluation. International Journal of Environmental Research and Public Health, 19(18). [More Information]
Semsarian, C., Ma, T., Nickel, B., Scolyer, R., Ferguson, P., Soyer, H., Parker, L., Barratt, A., Thompson, J., Bell, K. (2022). Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? British Journal of Dermatology, 186(6), 1030-1032. [More Information]
Bell, K., White, S., Hassan, O., Zhu, L., Scott, A., Clark, J., Glasziou, P. (2022). Evaluation of the Incremental Value of a Coronary Artery Calcium Score Beyond Traditional Cardiovascular Risk Assessment: A Systematic Review and Meta-analysis. JAMA Internal Medicine, 182(6), 634-642. [More Information]
Drabarek, D., Habgood, E., Janda, M., Hersch, J., Ackermann, D., Low, D., Low, C., Morton, R., Dieng, M., Cust, A., Morgan, A., Smith, E., Bell, K. (2022). Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study. JMIR Dermatology, 5(3). [More Information]
Petersen, M., Bell, K., Pickles, K., McGain, F., McAlister, S., Barratt, A. (2022). Health, financial and environmental impacts of unnecessary vitamin D testing: A triple bottom line assessment adapted for healthcare. BMJ Open, 12(8). [More Information]
Barratt, A., Bell, K., Charlesworth, K., McGain, F. (2022). High value health care is low carbon health care. Medical Journal of Australia, 216(2), 67-68. [More Information]
Harhay, M., Bell, K., Huang, J., Arah, O. (2022). IJE's Education Corner turns 10! Looking back and looking forward. International Journal of Epidemiology, 51(5), 1357-1360. [More Information]
Pathirana, T., Pickles, K., Riikonen, J., Tikkinen, K., Bell, K., Glasziou, P. (2022). Including Information on Overdiagnosis in Shared Decision Making: A Review of Prostate Cancer Screening Decision Aids. MDM Policy and Practice, 7(2). [More Information]
Kazda, L., McGeechan, K., Bell, K., Thomas, R., Barratt, A. (2022). Increased diagnosis of attention-deficit hyperactivity disorder despite stable hyperactive/inattentive behaviours: evidence from two birth cohorts of Australian children. The Journal of Child Psychology and Psychiatry. [More Information]
Besser, R., Bell, K., Couper, J., Ziegler, A., Wherrett, D., Knip, M., Speake, C., Casteels, K., Driscoll, K., Jacobsen, L., Craig, M., et al (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents. Pediatric Diabetes, 23(8), 1175-1187. [More Information]
Bell, K., Zhu, L., Glasziou, P. (2022). Keeping Score-Appropriate and Timely Use of CACS-Reply. JAMA Internal Medicine, 182(11), 1233-1234. [More Information]
Gregory, G., Zhu, L., Hayen, A., Bell, K. (2022). Learning from the pandemic: Mortality trends and seasonality of deaths in Australia in 2020. International Journal of Epidemiology, 51(3), 718-726. [More Information]
Bell, K., Nijsten, T. (2022). Melanoma overdiagnosis: why it matters and what can be done about it. British Journal of Dermatology, 187(4), 459-460. [More Information]
Drabarek, D., Habgood, E., Ackermann, D., Hersch, J., Janda, M., Morton, R., Guitera, P., Peter Soyer, H., Collgros Totosaus, H., Cust, A., Saw, R., Dieng, M., Bell, K., et al (2022). Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study. JMIR Dermatology, 5(4). [More Information]
Meiser, B., Woodward, P., Gleeson, M., Kentwell, M., Mar Fan, H., Antill, Y., Butow, P., Boyle, F., Best, M., Taylor, N., Bell, K., et al (2022). Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients. Familial Cancer, 21(2), 157-166. [More Information]
Arroyo, N., Bell, K., Hsiao, V., Fernandes-Taylor, S., Alagoz, O., Zhang, Y., Davies, L., Francis, D. (2022). Prevalence of Subclinical Papillary Thyroid Cancer by Age: Meta-analysis of Autopsy Studies. Journal of Clinical Endocrinology and Metabolism, 107(10), 2945-2952. [More Information]
White, S., Gong, H., Zhu, L., Doust, J., Loh, T., Lord, S., Horvath, A., McGeechan, K., Bell, K. (2022). Simulations found within-subject measurement variation in glycaemic measures may cause overdiagnosis of prediabetes and diabetes. Journal of Clinical Epidemiology, 145, 20-28. [More Information]
Muscat, D., Cvejic, E., Bell, K., Smith, J., Morris, G., Jansen, J., Thomas, R., Bonner, C., Doust, J., McCaffery, K. (2022). The impact of health literacy on psychosocial and behavioural outcomes among people at low risk of cardiovascular disease. Preventive Medicine, 156, 106980. [More Information]
Pathirana, T., Sequeira, R., Del Mar, C., Dickinson, J., Armstrong, B., Bell, K., Glasziou, P. (2022). Trends in Prostate Specific Antigen (PSA) testing and prostate cancer incidence and mortality in Australia: A critical analysis. Cancer Epidemiology, 77, 102093-1-102093-6. [More Information]
Keers, G., Yamada, K., Pickles, K., Bell, K., Black, K., Bateson, D., Dodd, R. (2022). Understanding women’s choices for management of cervical intraepithelial neoplasia 2 (CIN2): Qualitative analysis of a randomised experimental study. Australian and New Zealand Journal of Obstetrics and Gynaecology, 62(1), 125-132. [More Information]
Luigjes-Huizer, Y., Tauber, N., Humphris, G., Kasparian, N., Lam, W., Lebel, S., Simard, S., Smith, A., Zachariae, R., Afiyanti, Y., Bell, K., et al (2022). What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psycho-Oncology, 31(6), 879-892. [More Information]

show 27 more

2021

Zhu, L., Bell, K., Nayak, A., Hayen, A. (2021). A methods review of posttrial follow-up studies of cardiovascular prevention finds potential biases in estimating legacy effects. Journal of Clinical Epidemiology, 131, 51-58. [More Information]
Dodd, R., Cvejic, E., Bell, K., Black, K., Bateson, D., Smith, M., Mac, O., McCaffery, K. (2021). Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study. Gynecologic Oncology, 161(1), 179-187. [More Information]
Muscat, D., Morris, G., Bell, K., Cvejic, E., Smith, J., Jansen, J., Thomas, R., Bonner, C., Doust, J., McCaffery, K. (2021). Benefits and Harms of Hypertension and High-Normal Labels: A Randomized Experiment. Circulation: Cardiovascular Quality and Outcomes, 14(4):e007160(4), e007160. [More Information]
Ackermann, D., Smit, A., Janda, M., Van Kemenade, C., Dieng, M., Morton, R., Turner, R., Cust, A., Irwig, L., Hersch, J., Guitera, P., Saw, R., Drabarek, D., Espinoza, D., Thompson, J., Scolyer, R., Bell, K., et al (2021). Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial. Trials, 22(1), 324. [More Information]
Byambasuren, O., Dobler, C., Bell, K., Rojas, D., Clark, J., McLaws, M., Glasziou, P. (2021). Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review. PloS One, 16, e0248946. [More Information]
Stanaway, F., Irwig, L., Teixeira-Pinto, A., Bell, K. (2021). COVID-19: estimated number of deaths if Australia had experienced a similar outbreak to England and Wales. Medical Journal of Australia, 214(2), 95-9.50E+02. [More Information]
Leeflang, M., Bell, K., Deeks, J., Dinnes, J., Doust, J., Korevaar, D., Lord, S., Spijker, R. (2021). Electronic and animal noses for detecting SARS-CoV-2 infection. The Cochrane Library Chichester UK: John Wiley and Sons Ltd, 2021 (6). [More Information]
Bell, K., Glasziou, P., Stanaway, F., Bossuyt, P., Irwig, L. (2021). Equity and evidence during vaccine rollout: stepped wedge cluster randomised trials could help. BMJ, 372, n435. [More Information]
Gibson, M., Scolyer, R., Soyer, H., Ferguson, P., McGeechan, K., Irwig, L., Bell, K. (2021). Estimating the potential impact of interventions to reduce over-calling and under-calling of melanoma. Journal of the European Academy of Dermatology and Venereology, 35(7), 1519-1527. [More Information]
Leclair, K., Bell, K., Furuya-Kanamori, L., Doi, S., Francis, D., Davies, L. (2021). Evaluation of Gender Inequity in Thyroid Cancer Diagnosis: Differences by Sex in US Thyroid Cancer Incidence Compared with a Meta-analysis of Subclinical Thyroid Cancer Rates at Autopsy. JAMA Internal Medicine, 181(10), 1351-1358. [More Information]
Doust, J., Bell, K., Leeflang, M., Dinnes, J., Lord, S., Mallett, S., Van De Wijgert, J., Sandberg, S., Adeli, K., Deeks, J., Horvath, A., et al (2021). Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection. BMJ, 372, n568. [More Information]
Bell, K., Stanaway, F., Irwig, L., Horvath, A., Teixeira-Pinto, A., Loy, C. (2021). How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions. Medical Journal of Australia, 214(2), 69-7.30E+02. [More Information]
Katz, I., Irwig, L., McGeehan, K., Bell, K. (2021). I need an exact margin measurement for this basal cell carcinoma!. Journal of Clinical Pathology. [More Information]
Farber, R., Houssami, N., Wortley, S., Jacklyn, G., Marinovich, M., McGeechan, K., Barratt, A., Bell, K. (2021). Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis. Journal of the National Cancer Institute, 113(1), 16-26. [More Information]
Bell, K., Loy, C., Cust, A., Teixeira-Pinto, A. (2021). Mendelian Randomization in Cardiovascular Research: Establishing Causality When There Are Unmeasured Confounders. Circulation: Cardiovascular Quality and Outcomes, 14(1), e005623. [More Information]
Kazda, L., Bell, K., Thomas, R., McGeechan, K., Sims, R., Barratt, A. (2021). Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review. JAMA Network Open, 4(4), e215335. [More Information]
Bell, K., Doust, J., McGeechan, K., Barratt, A., Hayen, A., Semsarian, C., Irwig, L. (2021). Reply. Journal of Hypertension, 39(5), 1045-1046. [More Information]
Ma, T., Semsarian, C., Barratt, A., Parker, L., Kumarasinghe, M., Bell, K., Nickel, B. (2021). Rethinking Low-Risk Papillary Thyroid Cancers < 1cm (Papillary Microcarcinomas): An Evidence Review for Recalibrating Diagnostic Thresholds and/or Alternative Labels. Thyroid, 31(11), 1626-1638. [More Information]
Loh, T., Smith, A., Bell, K., Lord, S., Ceriotti, F., Jones, G., Bossuyt, P., Sandberg, S., Horvath, A. (2021). Setting analytical performance specifications using HbA1c as a model measurand. Clinica Chimica Acta, 523, 407-414. [More Information]
Loh, T., Lord, S., Bell, K., Bohn, M., Lim, C., Markus, C., Fares Taie, H., Adeli, K., Lippi, G., Sandberg, S., et al (2021). Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing. Clinical Biochemistry, 88, 18-22. [More Information]
Bell, K., McGeechan, K., Horvath, A., Barratt, A., Hayen, A., Semsarian, C., Irwig, L. (2021). The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines. Journal of Hypertension, 39(2), 236-242. [More Information]
Karki, S., Davison, T., Liu, B., Bell, K., Olynyk, J., Hayen, A., Irving, D. (2021). Visits to general practitioners after iron-related deferrals from blood donation in middle-aged and older Australian blood donors. Transfusion, 61(12), 3335-3343. [More Information]
Doust, J., Treadwell, J., Bell, K. (2021). Widening Disease Definitions: What Can Physicians Do? American Family Physician, 103(3), 138-140.
Karki, S., Gemelli, C., Davison, T., Masser, B., Marks, D., Bell, K., Liu, B., Hayen, A., van den Hurk, K., Irving, D. (2021). Willingness of blood donors in Australia to provide additional data and blood sample for health research. Transfusion, 61(10), 2855-2861. [More Information]

show 21 more

2020

Bell, K. (2020). Causal inference in melanoma epidemiology using Mendelian randomization. British Journal of Dermatology, 182(1), 7-23. [More Information]
Byambasuren, O., Cardona, M., Bell, K., Clark, J., McLaws, M., Glasziou, P. (2020). Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. Association of Medical Microbiology and Infectious Disease Canada. Journal, 5(4), 223-234. [More Information]
Glasziou, P., Jones, M., Pathirana, T., Barratt, A., Bell, K. (2020). Estimating the magnitude of cancer overdiagnosis in Australia. Medical Journal of Australia, 212(4), 163-168. [More Information]
Glasziou, P., Bell, K., Barratt, A. (2020). Estimating the magnitude of cancer overdiagnosis in Australia. Medical Journal of Australia, 213(4), 189-189.e1. [More Information]
Doust, J., Bonner, C., Bell, K. (2020). Future directions in cardiovascular disease risk prediction. Australian Journal of General Practice, 49(8), 488-494. [More Information]
Bach, A., Lo, K., Pathirana, T., Glasziou, P., Barratt, A., Jones, M., Bell, K. (2020). Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk. Medical Journal of Australia, 212(1), 17-22. [More Information]
Zhu, L., Hayen, A., Bell, K. (2020). Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study. Cardiovascular Diabetology, 19(1), 28. [More Information]
Bell, K., Irwig, L., Nickel, B., Hersch, J., Hayen, A., Barratt, A. (2020). Mammography screening for breast cancer—the UK Age trial. The Lancet Oncology, 21(11), e504. [More Information]
Doust, J., Bell, K., Glasziou, P. (2020). Potential Consequences of Changing Disease Classifications. JAMA, 323(10), 921-922. [More Information]
McAlister, S., Barratt, A., Bell, K., McGain, F. (2020). The carbon footprint of pathology testing. Medical Journal of Australia, 212(8), 377-382. [More Information]
Oremus, M., Taylor-Wilson, R., Aldrich, M., Bell, K., Gaudino, J., Payne, J., Raynes-Greenow, C., Sim, F., Smith, M., Weiss, S., Zhang, Y. (2020). The role of epidemiologists in SARS-CoV-2 and COVID-19 research. Public Health, 190, e3-e4. [More Information]
Smith, L., Barratt, A., Buchbinder, R., Harris, I., Doust, J., Bell, K. (2020). Trends in knee magnetic resonance imaging, arthroscopies and joint replacements in older Australians: still too much low-value care? ANZ Journal of Surgery, 90(5), 833-839. [More Information]
Lam, J., Pickles, K., Stanaway, F., Bell, K. (2020). Why clinicians overtest: development of a thematic framework. BMC Health Services Research, 20(1), 1011. [More Information]
Bell, K., Semsarian, C., Doust, J. (2020). Why We Might Not Need to Stress About Ruling Out Inducible Myocardial Ischemia. Annals of Internal Medicine, 172(3), 214-215. [More Information]

show 11 more

2019

Zhu, L., Bell, K., Hayen, A. (2019). Estimated legacy effects from simulated post-trial data were less biased than from combined trial/post-trial data. Journal of Clinical Epidemiology, 114, 30-37. [More Information]
Kazda, L., Bell, K., Thomas, R., McGeechan, K., Barratt, A. (2019). Evidence of potential overdiagnosis and overtreatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents: protocol for a scoping review. BMJ Open, 9(11), 1-5. [More Information]
Bonner, C., McKinn, S., McCaffery, K., Glasziou, P., Irwig, L., Doust, J., Jansen, J., Bell, K. (2019). Is the NHS 'Heart Age Test' too much medicine? British Journal of General Practice, 69(688), 560-561. [More Information]
Pathirana, T., Hayen, A., Doust, J., Glasziou, P., Bell, K. (2019). Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach. BMJ Open, 9(3), 1-7. [More Information]
Dieng, M., Smit, A., Hersch, J., Morton, R., Cust, A., Irwig, L., Low, D., Low, C., Bell, K. (2019). Patients' Views About Skin Self-examination After Treatment for Localized Melanoma. JAMA Dermatology, 155(8), 914-921. [More Information]
Thomas, E., Guppy, M., Straus, S., Bell, K., Glasziou, P. (2019). Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies. BMJ Open, 9(6), 1-13. [More Information]
Bell, K., Doust, J., Glasziou, P., Cullen, L., Harris, I., Smith, L., Buchbinder, R., Barratt, A. (2019). Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example? Annals of Internal Medicine, 170(4), 259-261. [More Information]
Thurber, K., Bell, K. (2019). Socio-economic disadvantage and cardiovascular risk factors in young Aboriginal and Torres Strait Islander Australians. Medical Journal of Australia, 211, 259-260. [More Information]
Bell, K., Macaskill, P., Loy, C. (2019). Test accuracy and potential sources of bias in diagnostic test evaluation. Medical Journal of Australia, 212(1), 10-1.30E+02. [More Information]

show 6 more

2018

Morony, S., Weir, K., Bell, K., Biggs, J., Duncan, G., Nutbeam, D., McCaffery, K. (2018). A stepped wedge cluster randomised trial of nurse-delivered Teach-Back in a consumer telehealth service. PloS One, 13(10), 1-20. [More Information]
Bell, K., Cust, A. (2018). Beyond country-specific incidence and mortality: the global burden of melanoma. British Journal of Dermatology, 178(2), 315-316. [More Information]
Barratt, A., Bell, K., Jacklyn, G. (2018). Demonstration of Classic Screening Biases, Not Additional Benefit of Annual Over Biennial Screening. Journal of the American College of Radiology, 15(10), 1360. [More Information]
Bell, K., Doust, J., Glaszious, P. (2018). Incremental Benefits and Harms of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. JAMA Internal Medicine, 178(6), 755-757. [More Information]
Nayak, A., Hayen, A., Zhu, L., McGeechan, K., Glasziou, P., Irwig, L., Doust, J., Gregory, G., Bell, K. (2018). Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis. BMJ Open, 8(9), 1-11. [More Information]
Jacklyn, G., McGeechan, K., Houssami, N., Bell, K., Glasziou, P., Barratt, A. (2018). Overdiagnosis due to screening mammography for women aged 40 years and over [Intervention Protocol]. Cochrane Database of Systematic Reviews, 2018 (7), 1-17. [More Information]
Lim, W., Morton, R., Turner, R., Jenkins, M., Guitera, P., Irwig, L., Webster, A., Dieng, M., Saw, R., Low, D., Bell, K., et al (2018). Patient preferences for follow-up after recent excision of a localized melanoma. JAMA Dermatology, 154(4), 420-427. [More Information]
Hajati, F., Atlantis, E., Bell, K., Girosi, F. (2018). Patterns and trends of potentially inappropriate high-density lipoprotein cholesterol testing in Australian adults at high risk of cardiovascular disease from 2008 to 2014: analysis of linked individual patient data from the Australian Medicare Benefits Schedule and Pharmaceutical Benefits Scheme. BMJ Open, 8(3), 1-10. [More Information]
Bell, K., Azizi, L., Nilsson, P., Hayen, A., Irwig, L., Ostgren, C., Sundrom, J. (2018). Prognostic impact of systolic blood pressure variability in people with diabetes. PloS One, 13(4), 1-11. [More Information]
Bonner, C., Bell, K., Jansen, J., Glasziou, P., Irwig, L., Doust, J., McCaffery, K. (2018). Should heart age calculators be used alongside absolute cardiovascular disease risk assessment? BMC Cardiovascular Disorders, 18(1), 1-8. [More Information]
Bell, K., Cust, A., Scolyer, R. (2018). The importance of population-based estimates of melanocytic pathology. JAMA Dermatology, 154(1), 15-17. [More Information]
Lim, W., Turner, R., Morton, R., Jenkins, M., Irwig, L., Webster, A., Dieng, M., Saw, R., Guitera, P., Low, D., Bell, K., et al (2018). Use of shared care and routine tests in follow-up after treatment for localised cutaneous melanoma. BMC Health Services Research, 18(1), 1-9. [More Information]

show 9 more

2017

Jacklyn, G., Bell, K., Hayen, A. (2017). Assessing the efficacy of cancer screening. Public Health Research and Practice, 27(3), 1-6. [More Information]
Bell, K., Hayen, A., Glasziou, P., Irwig, L., Bauer, D. (2017). Change in bone mineral density is an indicator of treatment-related antifracture effect. Annals of Internal Medicine, 166(2), 152-152. [More Information]
Bell, K., Hayen, A., Glasziou, P., Mitchell, A., Farris, M., Wright, J., Duerr, H., Mitchell, P., Irwig, L. (2017). Early CRT monitoring using time-domain optical coherence tomography does not add to visual acuity for predicting visual loss in patients with central retinal vein occlusion treated with intravitreal ranibizumab a secondary analysis of trial data. Retina, 37(3), 509-514. [More Information]
Bell, K., Mehta, Y., Turner, R., Morton, R., Dieng, M., Saw, R., Guitera, P., McCaffery, K., Low, D., Low, C., Jenkins, M., Irwig, L., Webster, A. (2017). Fear of new or recurrent melanoma after treatment for localised melanoma. Psycho-Oncology, 26(11), 1784-1791. [More Information]
Jansen, J., McKinn, S., Bonner, C., Irwig, L., Doust, J., Glasziou, P., Bell, K., Naganathan, V., McCaffery, K. (2017). General practitioners' decision making about primary prevention of cardiovascular disease in older adults: A qualitative study. PloS One, 12(1), 1-13. [More Information]
Thomas, E., Del Mar, C., Glasziou, P., Wright, G., Barratt, A., Bell, K. (2017). Prevalence of incidental breast cancer and precursor lesions in autopsy studies: A systematic review and meta-analysis. BMC Cancer, 17(1), 1-10. [More Information]
Sanders, S., Rathbone, J., Bell, K., Glasziou, P., Doust, J. (2017). Systematic review of the effects of care provided with and without diagnostic clinical prediction rules. Diagnostic and Prognostic Research, 1(1), 1-17. [More Information]
Jacklyn, G., McGeechan, K., Irwig, L., Houssami, N., Morrell, S., Bell, K., Barratt, A. (2017). Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography. Breast Cancer Research and Treatment, 166(3), 843-854. [More Information]
Bell, K., McCullough, A., Del Mar, C., Glasziou, P. (2017). What's the uptake? Pragmatic RCTs may be used to estimate uptake, and thereby population impact of interventions, but better reporting of trial recruitment processes is needed. BMC Medical Research Methodology, 17(1), 1-7. [More Information]

show 6 more

2016

Bell, K., Hayen, A., Glasziou, P., Irwig, L., Eastell, R., Harrison, S., Black, D., Bauer, D. (2016). Potential Usefulness of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy Among Women With Osteoporosis: Secondary Analysis of Randomized Controlled Trial Data. Journal of Bone and Mineral Research, 31(9), 1767-1773. [More Information]
Furuya-Kanamori, L., Bell, K., Clark, J., Glasziou, P., Doi, S. (2016). Prevalence of differentiated thyroid cancer in autopsy studies over six decades: A meta-analysis. Journal of Clinical Oncology, 34(30), 3672-3679. [More Information]

2015

Bell, K., Bossuyt, P., Glasziou, P., Irwig, L. (2015). Assessment of changes to screening programmes: why randomisation is important. BMJ, 350, 1-4. [More Information]
Memari, N., Hayen, A., Bell, K., Rychetnik, L., Morton, R., McCaffery, K., Thompson, J., Irwig, L., Turner, R. (2015). How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center? Annals of Surgical Oncology, 22(Supp 3), 1164-1171. [More Information]
Bell, K., Del Mar, C., Wright, G., Dickinson, J., Glasziou, P. (2015). Prevalence of incidental prostate cancer: A systematic review of autopsy studies. International Journal of Cancer, 137(7), 1749-1757. [More Information]
Bell, K., McCaffery, K., Irwig, L. (2015). Screening tests for gonorrhoea should first do no harm. Medical Journal of Australia, 202(6), 281-282. [More Information]

show 1 more

2014

Bell, K., Beller, E., Sundstrom, J., McGeechan, K., Hayen, A., Irwig, L., Neal, B., Glasziou, P. (2014). Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data. BMJ Open, 4(9), 1-9. [More Information]
Bell, K., Glasziou, P., Hayen, A., Irwig, L. (2014). Criteria for monitoring tests were described: validity, responsiveness, detectability of long-term change, and practicality. Journal of Clinical Epidemiology, 67(2), 152-159. [More Information]

2013

Bell, K., Hayen, A., Irwig, L., Takahashi, O., Ohde, S., Glasziou, P. (2013). When to remeasure cardiovascular risk in untreated people at low and intermediate risk: observational study. BMJ, 346(7906), 1-8. [More Information]

2012

Hayden, A., Bell, K., Glasziou, P., Irwig, L. (2012). A counterargument to encounter frequency and target achievement: measurement variability. Archives of Internal Medicine, 172(4), 374-375. [More Information]
Bell, K., Hayen, A., McGeechan, K., Neal, B., Irwig, L. (2012). Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk. European Journal of Preventive Cardiology, 19(6), 1474-1485. [More Information]
Bell, K., Hayen, A., Irwig, L., Hochberg, M., Ensrud, K., Cummings, S., Bauer, D. (2012). The Potential Value of Monitoring Bone Turnover Markers Among Women on Alendronate. Journal of Bone and Mineral Research, 27(1), 195-201. [More Information]

2011

Bell, K., Kirby, A., Hayen, A., Irwig, L., Glasziou, P. (2011). Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data. BMJ: British Medical Journal, 342(7791), 1-7. [More Information]
Turner, R., Bell, K., Morton, R., Hayen, A., Francken, A., Howard, K., Armstrong, B., Thompson, J., Irwig, L. (2011). Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma. Journal of Clinical Oncology, 29(35), 4641-4646. [More Information]

2010

Hayen, A., Bell, K., Glasziou, P., Neal, B., Irwig, L. (2010). Monitoring Adherence to Medication by Measuring Change in Blood Pressure. Hypertension, 56(4), 612-616. [More Information]
Bell, K., Hayen, A., Macaskill, P., Craig, J., Neal, B., Fox, K., Remme, W., Asselbergs, F., van Gilst, W., MacMahon, S., Irwig, L., et al (2010). Monitoring Initial Response to Angiotensin-Converting Enzyme Inhibitor-Based Regimens. An Individual Patient Data Meta-Analysis From Randomized, Placebo-Controlled Trials. Hypertension, 56(3), 533-539. [More Information]
Bell, K., Irwig, L., Hayen, A., Macaskill, P., Craig, J. (2010). Should response rules be used to decide continued subsidy of very expensive drugs? A checklist for decision makers. Pharmacoepidemiology and Drug Safety, 19(1), 99-105. [More Information]
Bell, K., Hayen, A., Irwig, L., Macaskill, P., Craig, J., Ensrud, K., Bauer, D. (2010). The Value of Routine BMD Monitoring After Starting Bisphosphonate Treatment. Journal of Bone and Mineral Research, 25(1), 173-174. [More Information]

show 1 more

2009

Gupta, S., Wratten, C., Kilmurray, J., Nash, S., Seldon, M., O'Brien, P., Bell, K., Denham, J. (2009). Is there a relationship between skin erythema and fatigue in women undergoing irradiation after breast conserving surgery for early breast cancer? A prospective study. Asia-Pacific Journal of Clinical Oncology, 5(4), 257-263. [More Information]
Bell, K., Hayen, A., Macaskill, P., Craig, J., Neal, B., Irwig, L. (2009). Mixed models showed no need for initial response monitoring after starting antihypertensive therapy. Journal of Clinical Epidemiology, 62, 650-659. [More Information]
Lincz, L., Gupta, S., Wratten, C., Kilmurray, J., Nash, S., Seldon, M., O'Brien, P., Bell, K., Denham, J. (2009). Thrombin generation as a predictor of radiotherapy induced skin erythema. Radiotherapy and Oncology, 90(1), 136-140. [More Information]
Bell, K., Hayen, A., Macaskill, P., Irwig, L., Craig, J., Ensrud, K., Bauer, D. (2009). Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ: British Medical Journal, 338(7710), 1-5. [More Information]

show 1 more

2008

Bell, K., Craig, J., Irwig, L. (2008). Monitoring the initial response to treatment. In P Glasziou, L Irwig and J K Aronson (Eds.), Evidence-based Medical Monitoring:From Principles to Practice, (pp. 75-89). Oxford: Blackwell Publishers. [More Information]
Bell, K., Irwig, L., Craig, J., Macaskill, P. (2008). Use of randomised trials to decide when to monitor response to new treatment. BMJ: British Medical Journal, 336, 361-365. [More Information]

2003

Bell, K., Wattie, M., Byth Wilson, K., Silvestrini, R., Clark, P., Stachowski, E., Benson, E. (2003). Procalcitonin: A marker of bacteraemia is SIRS. Anaesthesia and Intensive Care, 31(6), 629-636.

Selected Grants

2024

FIND-MEL: Developing an application for FollowingImages of Nevi to Detect Melanoma, Bell K, US Department of Defence (USA)/Research Support

2023

Rewarding Research 2024, Bell K, Faculty of Medicine and Health/FMH Rewarding Research Success
Preventing Overdiagnosis 2023 International Conference, Bell K, National Heart Foundation of Australia/2023 NSW Cardiovascular Research Network Professional Development Award

2022

GenE4newborns. The Ethics, Equity, Efficiency and Economics of genomic newborn screeningS, Norris S, Howard K, Newson A, Kariyawasam D, Watson J, Garvey G, Carter S, Wordsworth S, Bell K, Nowak K, Baynam G, Craig J, Mordaunt D, Kylie M, Otlowski M, Department of Health and Aged Care (Federal)/MRFF - Genomic Health Futures Mission (GHFM) - Genomics Health Futures Mission Grant

2021

Wiser healthcare: better value care for all Australians, McCaffery K, Carter S, Barratt A, Bell K, Moynihan R, O'Connor D, Maher C, Buchbinder R, Houssami N, Glasziou P, National Health and Medical Research Council (NHMRC)/Centres of Research Excellence

2020

Evidence on the clinical effectiveness and cost-effectiveness of digital breast tomosynthesis in identifying breast cancer compared to standard imaging in populations at risk of breast cancer, Houssami N, Bell K, Nickson C, Teixeira-Pinto A, Askie L, Lockie D, Noguchi N, Department of Health and Aged Care (Federal)/MRFF - Preventive and Public Health Research - Targeted Health System & Community Organisation

2019

USING EARLY DETECTION TESTS TO BENEFIT HEALTH WITHOUT CAUSING HARM, Bell K, National Health and Medical Research Council (NHMRC)/Investigator Grant

2018

Can NZ PREDICT equations predict cardiovascular disease in Australians better than the Framingham risk equation, Bell K, Foundation for High Blood Pressure Research/Early Career Research Transition Grant
Can patient-led surveillance detect recurrent or new primary melanomas A Randomised Controlled Trial, Bell K, Janda M, Cust A, Turner R, Guitera P, Irwig L, Guitera P, Saw R, Mar V, Dieng M, Hersch J, National Health and Medical Research Council (NHMRC)/Project Grants

2016

Katy Bell Bridging Support Grant, Bell K, DVC Research/Bridging Support Fellowship

2010

Optimising the monitoring of cardiovascular risk, Bell K, National Health and Medical Research Council (NHMRC)/Early Career Fellowships

Faculty of Medicine and Health

Page not found

Professor Katy Bell

Publications

By Type

By Year

Selected Grants

2024

2023

2022

2021

2020

2019

2018

2016

2010

Related research articles

When the media reports on celebrity cancer are we really getting the whole story

Medicine and health researchers honoured with NHMRC Research Excellence Awards

Pandemic response led to a drop in Australian deaths in 2020

Culling low value care will cut healthcare s carbon emissions

How doctors can have more confidence in a COVID19 diagnosis analysis

Reform needed to counter cancer overdiagnosis

Are we overestimating lifetime cancer risks

Helping Sydney researchers to SOAR

Blood pressure - new guidelines could put lives at risk